KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Return on Sales (2016 - 2025)

Historic Return on Sales for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to 0.08%.

  • Fulgent Genetics' Return on Sales rose 1200.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 4400.0%. This contributed to the annual value of 0.15% for FY2024, which is 4100.0% up from last year.
  • According to the latest figures from Q3 2025, Fulgent Genetics' Return on Sales is 0.08%, which was up 1200.0% from 0.23% recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Return on Sales registered a high of 0.56% during Q1 2021, and its lowest value of 1.74% during Q4 2023.
  • Its 5-year average for Return on Sales is 0.06%, with a median of 0.13% in 2024.
  • As far as peak fluctuations go, Fulgent Genetics' Return on Sales crashed by -13900bps in 2023, and later soared by 16600bps in 2024.
  • Over the past 5 years, Fulgent Genetics' Return on Sales (Quarter) stood at 0.41% in 2021, then tumbled by -186bps to 0.36% in 2022, then crashed by -390bps to 1.74% in 2023, then skyrocketed by 95bps to 0.08% in 2024, then increased by 1bps to 0.08% in 2025.
  • Its Return on Sales was 0.08% in Q3 2025, compared to 0.23% in Q2 2025 and 0.16% in Q1 2025.